Jm-27 asa a marker of benign prostatic hyperplasia

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) G01N 33/574 (2006.01)

Patent

CA 2571154

A serum assay for JM-27 identifies individuals having benign prostate hyperplasia (BPH). by means of the serum assay, methods of diagnosing BPH, methods of determining the severity of , methods of monitoring the course of therapy and methods of monitoring the progression of are performed.

Selon l'invention, une épreuve sérologique pour JM-27 identifie des individus atteints d'une hypertrophie bénigne de la prostate (HBP). Cette épreuve sérologique permet de mettre en oeuvre des procédés de diagnostic d'une HBP, des procédés pour déterminer la gravité d'une HBP, des procédés de contrôle de l'évolution du traitement d'une HBP et des procédés de contrôle de la progression d'une HBP.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Jm-27 asa a marker of benign prostatic hyperplasia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Jm-27 asa a marker of benign prostatic hyperplasia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Jm-27 asa a marker of benign prostatic hyperplasia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1846987

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.